Patents by Inventor Jamila Louhed

Jamila Louhed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated nucleic acid molecules encoding T cell derived inducible factors
    Patent number: 7081528
    Abstract: The invention involves isolation of nucleic acid molecules, the expression of which are upregulated by interleukin-9. The amino acid sequences of the proteins which correspond to the nucleic acid molecules show some structural features of cytokines. In addition to the nucleic acid molecules and the proteins, various uses of the molecules are disclosed. The molecules are referred to as T cell inducible factors.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: July 25, 2006
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Laure Dumoutier, Jamila Louhed, Jean-Christophe Renauld
  • Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses therefor
    Patent number: 6359117
    Abstract: The invention involves isolation of nucleic acid molecules, the expression of which are upregulated by interleukin-9. The amino acid sequences of the proteins which correspond to the nucleic acid molecules show some structural features of cytokines. In addition to the nucleic acid molecules and the proteins, various uses of the molecules are disclosed. The molecules are referred to as T cell inducible factors.
    Type: Grant
    Filed: July 16, 1999
    Date of Patent: March 19, 2002
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Laure Dumoutier, Jamila Louhed, Jean-Christophe Renauld
  • Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof
    Patent number: 6331613
    Abstract: The invention involves isolation of nucleic acid molecules, the expression of which are upregulated by interleukin-9. The amino acid sequences of the proteins which correspond to the nucleic acid molecules show some structural features of cytokines. In addition to the nucleic acid molecules and the proteins, various uses of the molecules are disclosed. The molecules are referred to as T cell inducible factors.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: December 18, 2001
    Assignee: Ludwig Institue for Cancer Research
    Inventors: Laure Dumoutier, Jamila Louhed, Jean-Christophe Renauld
  • Antibodies which specifically bind T Cell inducible factors (TIFs)
    Patent number: 6274710
    Abstract: The invention involves isolation of nucleic acid molecules, the expression of which are upregulated by interleukin-9. The amino acid sequences of the proteins which correspond to the nucleic acid molecules show some structural features of cytokines. In addition to the nucleic acid molecules and the proteins, various uses of the molecules are disclosed. The molecules are referred to as T cell induceable factors.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: August 14, 2001
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Laure Dumoutier, Jamila Louhed, Jean-Christophe Renauld